These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23839333)

  • 1. Current world literature. Hyperlipidaemia and cardiovascular disease.
    Curr Opin Lipidol; 2013 Aug; 24(4):357-62. PubMed ID: 23839333
    [No Abstract]   [Full Text] [Related]  

  • 2. Nutrition and metabolism: non-alcoholic fatty liver disease - pathogenesis, cardiovascular risk and therapy.
    Watts GF; Gan SK
    Curr Opin Lipidol; 2008 Feb; 19(1):92-4. PubMed ID: 18196992
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid metabolism in dialysis patients-the story gets more complicated.
    Ponda MP; Barash I
    Semin Dial; 2008; 21(5):390-4. PubMed ID: 18764791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrotendinous xanthomatosis.
    Sen A; Ghosh B; Kundu TN; Das SK; Sengupta SR
    J Assoc Physicians India; 2002 Sep; 50():1196-7. PubMed ID: 12516712
    [No Abstract]   [Full Text] [Related]  

  • 5. Dyslipidemia in renal disease: causes, consequences and treatment.
    Mesquita J; Varela A; Medina JL
    Endocrinol Nutr; 2010 Nov; 57(9):440-8. PubMed ID: 20850395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic dyslipidemia and cardiovascular risk.
    Eckel RH
    Curr Diab Rep; 2008 Dec; 8(6):421-3. PubMed ID: 18990296
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thyroid diseases, dyslipidemia and cardiovascular risk].
    Jiskra J; Límanová Z; Antosová M
    Vnitr Lek; 2007 Apr; 53(4):382-5. PubMed ID: 17578170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of smoking on diabetes mellitus and dyslipidemia (effect of smoking on glucose and lipid metabolism)].
    Saito K; Sone H
    Nihon Rinsho; 2013 Mar; 71(3):443-8. PubMed ID: 23631232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bibliography. Hyperlipidaemia and cardiovascular disease. Current world literature.
    Curr Opin Lipidol; 2012 Aug; 23(4):386-91. PubMed ID: 22801387
    [No Abstract]   [Full Text] [Related]  

  • 10. [The program of lowering of residual vascular risk (The Residual Vascular Risk Reduction Initiative). Part II. Methods of correction].
    Zubareva MIu; Susekov AV
    Kardiologiia; 2010; 50(9):64-70. PubMed ID: 21118169
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment.
    Quiat D; Olson EN
    J Clin Invest; 2013 Jan; 123(1):11-8. PubMed ID: 23281405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk.
    Wanner C; Drechsler C; Krane V
    J Ren Nutr; 2007 Jan; 17(1):75-8. PubMed ID: 17198938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of garlic allicor tablets on lipid metabolism and risk of fatal cardiovascular complications in patients with atherogenic dyslipoproteinemia].
    Gromnatskiĭ NI; Sereditskaia ZhE; Lazareva NV; Sereditskiĭ AV; Annenkova GV
    Vopr Pitan; 2007; 76(6):60-4. PubMed ID: 18219944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of alcohol, cocaine, and acquired immune deficiency.
    Brown J; King A; Francis CK
    Cardiovasc Clin; 1991; 21(3):341-76. PubMed ID: 2044115
    [No Abstract]   [Full Text] [Related]  

  • 15. Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?
    Daskalopoulos GN; Karkanaki A; Karagiannis A; Mikhailidis DP; Athyros VG
    Angiology; 2011 May; 62(4):285-90. PubMed ID: 21474465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL structure, function, therapeutics, and imaging.
    Hazen S
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):138. PubMed ID: 20089949
    [No Abstract]   [Full Text] [Related]  

  • 17. A neurological rarity not to be missed: cerebrotendinous xanthomatosis.
    Rafiq M; Sharrack N; Shaw PJ; Hadjivassiliou M
    Pract Neurol; 2011 Oct; 11(5):296-300. PubMed ID: 21921005
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrotendinous xanthomatosis with oromandibular dyskinesia.
    Bordia S; Saifee AA
    Neurol India; 2003 Dec; 51(4):556-8. PubMed ID: 14742951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-coaching strategies to improve patient-centered outcomes.
    Butterworth S
    J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 5):eS12-4. PubMed ID: 20430916
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.
    Carmena R
    Am Heart J; 2005 Nov; 150(5):859-70. PubMed ID: 16290951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.